PK sample analysis

SYRINX has extensive experience of developing new methods using state-of-the-art immunological and cell based techniques for pharmacokinetic (PK) sample analysis.


Immunogenicity testing

Our laboratory employs various plate and cellbased technologies, such as TR-FIA, ECL, AlphaLISA, iLITE, TR-FRET, RIA, SPR and ELISA, to assess the immunogenicity of biological drugs and vaccines.



SYRINX offers a wide range of biomarker assays to support your drug development program.



SYRINX is offering bioanalytics of biosimilars including PK, activity, binding and immunogenicity assays to demonstrate comparability of the biosimilar products to a reference or originator drug.


GMP analytics

SYRINX provides analytical services intended for the characterization or batch release certification of sponsor’s medicinal products using variety of different analysis techniques such as ligand binding and cell based assays.


Patient monitoring

Patient monitoring services are now available!

Concentration/activity analysis and immunogenicity testing using the iLite™ technology platform.


Over 20 years of experience

In GLP bioanalytics at your service

SYRINX Bioanalytics is a Contract Research Organization (CRO) offering a large variety of modern immunoassay techniques for the bioanalysis of Biologicals, Biosimilars, Anti-drug antibodies (immunogenicity testing) and Biomarkers.

SYRINX performs bioanalytical studies in compliance with GLP/GCP and supports GMP analysis for batch release and stability studies.

We are continuously striving to fulfil the latest guideline and white paper requirements offering innovative approaches utilising our strong scientific expertise and responsive communication with the focus on quality and on time delivery.

Company overview...


SYRINX Bioanalytics is included in the OECD principles of good laboratory practice (GLP) and EU good manufacturing practice (GMP analytics) monitoring programs.



SYRINX Bioanalytics offers a wide range of state-of-the-art assay techniques ideal for the bioanalysis of biologicals/biosimilars, anti-drug antibodies, vaccines and biomarkers.



SYRINX is a member of the European Bioanalysis Forum (EBF) together with more than 50 other Pharma and CRO companies.


News and events

Upcoming events:

SYRINX will attend the "EBF 12th Open Symposium: Imagine! - A New Bioanalytical Earthrise" 20-22 Nov 2019 in Barcelona, Spain.

Past EVENTS and news:

SYRINX attended the "EBF - Focus Workshop: Biomarker Assay Validation – Bringing Context of Use into practice" 19-20 Sep 2019 in Malaga, Spain.

SYRINX attended the EBF Workshop "ICH M10 - Public consultation & Industry Feedback Towards a Science based Global Bioanalytical GuidelineICH M10 - Public consultation & Industry Feedback Towards a Science based Global Bioanalytical Guideline" 20-22 May 2019 in Barcelona, Spain.

SYRINX attended the "9th Gene Quantification Event qPCR dPCR & NGS 2019" 18-22 Mar 2019 in Freising-Weihenstephan, Germany.

SYRINX attended the "Pharma Outsourcing" event 12 Dec 2018 in Stockholm, Sweden.

Immunogenicity analysis - determination of cut points. We use in-house validated MS Excel-templates for statistical evaluation of cut points according to Shankar et al. (Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products: J. Pharm. Biomed. Anal. 2008, 48/5: 1267-81) and Devanarayan et al. (Recommendations for Systematic Statistical Computation of Immunogenicity Cut Points: AAPS Journal 2017, 19/5: 1487–1498). More info can be requested by sending E-mail enquiry.